Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 29178607 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: a systematic review and meta-analysis. | |||||||
| 29360666 | HLA-CLASS II (HLA CLASS II) | lung transplantation | NA | NA | NA | unclassified | |
| we show in this retrospective study that specific donor hla class ii types are important in lung transplantation, because they are associated with either protection from or susceptibility to development of severe bos. | |||||||
| 29687961 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| donor-specific antibodies (dsa) to mismatched human leukocyte antigens (hla) are associated with worse outcomes after lung transplantation. | |||||||
| 29687961 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| we conclude that dsa occur frequently early after lung transplantation, and most target class ii hla. | |||||||
| 29976654 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| presence of anti-human leukocyte antigen donor-specific antibodies (dsas) is associated with poor outcome after lung transplantation. | |||||||
| 29997983 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| the presence of hla antibodies in transplant candidates and development of de novo antibodies after transplantation remain a major therapeutic challenge before and after lung transplantation. | |||||||
| 29997983 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| we also review strategies and evidence for hla desensitization prior to lung transplantation and management of de novo antibody formation after transplant. | |||||||
| 31005400 | NA (NA) | lung transplantation | NA | NA | NA | unclassified | |
| the impact of non-hla antibodies on outcomes after lung transplantation and implications for therapeutic approaches. | |||||||
| 31005400 | NA (NA) | lung transplantation | NA | NA | NA | unclassified | |
| however, there are emerging data that illustrate that non-hla antibodies can induce acute antibody-mediated rejection (amr) after lung transplantation. | |||||||
| 31164432 | HLA-G (HLA-G) | lung transplantation | NA | NA | NA | unclassified | |
| our aim was to investigate the association of donor and recipient hla-g snps with chronic lung allograft dysfunction (clad) and mortality after lung transplantation.in this single-centre study, we examined 11 hla-g snps in 345 consecutive recipients and 297 donors of a first bilateral lung transplant. | |||||||
Copyright 2024